Skip to main content
logo
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
100.61
+2.31 (2.35%)
At close: Sep 10, 2026, 4:00 PM EDT
101.00
+0.39 (0.39%)
After-hours: Sep 10, 2026, 7:30 PM EDT

Mirum Pharmaceuticals Revenue

Mirum Pharmaceuticals had revenue of $176.24M in the quarter ending June 30, 2026, with 37.92% growth. This brings the company's revenue in the last twelve months to $618.07M, up 44.02% year-over-year. In the year 2025, Mirum Pharmaceuticals had annual revenue of $521.31M with 54.74% growth.

Revenue (ttm)
$618.07M
Revenue Growth
+44.02%
P/S Ratio
10.48
Revenue / Employee
$1,427,406
Employees
433
Market Cap
6.53B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025521.31M184.42M54.74%
Dec 31, 2024336.89M150.51M80.76%
Dec 31, 2023186.37M109.31M141.85%
Dec 31, 202277.06M57.92M302.66%
Dec 31, 202119.14M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
PTC Therapeutics1.01B
Caris Life Sciences989.61M
Travere Therapeutics591.33M
Rhythm Pharmaceuticals239.92M
Xenon Pharmaceuticals7.50M
CG Oncology6.23M
Dianthus Therapeutics1.90M
Revenue Rankings

MIRM News

More News